改变做法以改善质瘤患者的生活质量
Catherine E Wassef1, Sarah A Cain2, Katharine J Drummond2,3
11Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York.
Journal of neurosurgery
|May 10, 2024
概括
改善质瘤患者的生存率需要专注于与健康相关的生活质量 (HRQOL). 影响HRQOL的关键因素包括疲劳,睡眠,情绪,认知和护理人员支持,需要有针对性的干预来获得更好的结果.
科学领域:
- 神经瘤学神经瘤学
- 生活质量研究 研究 生命质量研究
- 以患者为中心的护理
背景情况:
- 改善质瘤患者的生存率已经将重点转向与健康相关的生活质量 (HRQOL).
- HRQOL是一个关键的以患者为中心的指标,包括身体,情感和社会福祉.
- 神经外科医生需要了解手术结果之外的HRQOL决定因素.
研究的目的:
- 探索患者,社会,瘤和治疗相关的HRQOL在质瘤患者的决定因素.
- 确定影响HRQOL的关键因素,如疲劳,睡眠障碍,焦虑,抑郁,神经认知功能障碍,照顾者痛苦和生命终结问题.
- 审查以证据为基础的改善HRQOL的干预措施,并概述将HRQOL整合到神经外科护理中的计划.
主要方法:
- 对质瘤患者HRQOL决定因素的文献综述.
- 确定影响HRQOL的主要因素.
- 综合基于证据的干预措施和HRQOL整合的程序开发.
主要成果:
- 显著的HRQOL决定因素包括疲劳,睡眠障碍,焦虑,抑郁,神经认知功能障碍,护理人员困扰和生命结束的担忧.
- 基于证据的干预措施,如疲劳管理,认知康复,运动和息护理,可以改善HRQOL.
- 多学科的方法和综合的HRQOL计划对于提高患者福祉至关重要.
结论:
- 提高质瘤患者的生存率需要专注于改善与健康相关的生活质量 (HRQOL).
- 通过有针对性的干预措施解决疲劳,情绪,认知和护理人员痛苦等关键决定因素至关重要.
- 通过多学科计划将HRQOL整合到神经外科护理中,可以显著地使患者和工作人员受益.
更多相关视频
12:25Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
15.2K
05:45Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
Published on: January 19, 2024
1.8K
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...